130 related articles for article (PubMed ID: 3930749)
1. Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease.
Chandy KG; Pahl M; Vaziri ND; Gupta S
J Clin Lab Immunol; 1985 Jul; 17(3):119-24. PubMed ID: 3930749
[TBL] [Abstract][Full Text] [Related]
2. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
Raskova J; Ghobrial I; Shea SM; Ebert EC; Eisinger RP; Raska K
Diagn Immunol; 1986; 4(4):209-16. PubMed ID: 2944684
[TBL] [Abstract][Full Text] [Related]
3. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.
Raskova J; Ghobrial I; Czerwinski DK; Shea SM; Eisinger RP; Raska K
Arch Intern Med; 1987 Jan; 147(1):89-93. PubMed ID: 3492183
[TBL] [Abstract][Full Text] [Related]
4. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human lymphocyte responses in chronic renal failure mediated by adherent cells: analysis in serum-free media.
Kleiman KS; Zoschke DC
J Lab Clin Med; 1985 Sep; 106(3):262-8. PubMed ID: 3928781
[TBL] [Abstract][Full Text] [Related]
6. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
[TBL] [Abstract][Full Text] [Related]
7. Suppressor cell numbers and activity in non-transfused renal dialysis patients.
Smith MD; Hardy G; Williams JD; Coles GA
Clin Nephrol; 1983 Sep; 20(3):130-5. PubMed ID: 6226465
[TBL] [Abstract][Full Text] [Related]
8. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
[TBL] [Abstract][Full Text] [Related]
12. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
13. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S
Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325
[TBL] [Abstract][Full Text] [Related]
14. Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients.
Nanishi F; Inenaga T; Onoyama K; Oh Y; Oochi N; Fujishima M
J Clin Lab Immunol; 1986 Apr; 19(4):167-74. PubMed ID: 2941588
[TBL] [Abstract][Full Text] [Related]
15. The effect of hemodialysis on lymphocyte subsets during dialysis.
Chida Y; Sakurai S; Yoshiyama N
Clin Nephrol; 1986 Mar; 25(3):159-64. PubMed ID: 3754188
[TBL] [Abstract][Full Text] [Related]
16. Defective lymphoproliferative responses & interleukin-2 production in chronic renal failure patients.
Krishnamurthy G; Kher V; Naik S
Indian J Med Res; 1995 Dec; 102():281-6. PubMed ID: 8557322
[TBL] [Abstract][Full Text] [Related]
17. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
[TBL] [Abstract][Full Text] [Related]
18. [The ratio of the T lymphocyte subpopulation in patients on chronic hemodialysis].
Ljaljević J; Savin S; Veljović R; Ostrić V; Zlatković Lj
Glas Srp Akad Nauka Med; 1985; (37):109-16. PubMed ID: 3879872
[No Abstract] [Full Text] [Related]
19. T mediated immunity in patients undergoing periodic hemodialysis.
Piazza I; Alibrandi F; Semenzato G; Battistella L; Amadori G; Gasparotto G
Boll Ist Sieroter Milan; 1978 Nov; 57(5):631-6. PubMed ID: 314813
[TBL] [Abstract][Full Text] [Related]
20. Impaired T cell proliferation in acute dengue infection.
Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
